2,8-dihydroxyadenine

01/01/1999 - "Radiopaque 2,8-dihydroxyadenine lithiasis."
01/01/1988 - "2,8-Dihydroxyadenine lithiasis is rare. "
01/01/1988 - "New diagnostic and therapeutic aspects of 2,8-dihydroxyadenine lithiasis. "
10/31/1986 - "2,8-Dihydroxyadenine lithiasis."
01/01/1986 - "2,8-Dihydroxyadenine lithiasis--epidemiology, pathogenesis and therapy."

10/01/1981 - "We have recently been able to study renal biopsies from three related young women with an hereditary gout, and another girl with 2,8-dihydroxyadenine crystal nephropathy. "

03/01/2014 - "An APRT mutation is strongly associated with and likely causative for 2,8-dihydroxyadenine urolithiasis in dogs."
10/01/2011 - "We report the case of 2,8-dihydroxyadenine (DHA) urolithiasis in a 52-year-old male patient. "
08/01/2003 - "We report a case of 2,8-dihydroxyadenine (DHA) urolithiasis in a 28-year old female. "
02/09/1996 - "A fast and simple screening method for detection of 2,8-dihydroxyadenine urolithiasis by capillary zone electrophoresis."
12/01/1994 - "We treated two children with 2,8-dihydroxyadenine urolithiasis for over 7 years. "

04/01/2010 - "2,8-dihydroxyadenine nephrolithiasis induces developmental stage-specific alterations in gene expression in mouse kidney."
08/01/2000 - "Altered gene expression in kidneys of mice with 2,8-dihydroxyadenine nephrolithiasis."
04/01/2010 - "Mice with adenine phosphoribosyltransferase deficiency develop 2,8-dihydroxyadenine (DHA) nephrolithiasis. "
01/01/2002 - "Homozygous adenine phosphoribosyltransferase (APRT) deficiency is associated with 2,8-dihydroxyadenine (DHA) nephrolithiasis. "
08/01/2000 - "We have developed a knockout mouse model for adenine phosphoribosyltransferase (APRT) deficiency, a condition that often leads to 2,8-dihydroxyadenine (DHA) nephrolithiasis in humans. "

04/01/2014 - "It leads to the generation of large amounts of poorly soluble 2,8-dihydroxyadenine excreted in urine, yielding kidney injury and in some patients, kidney failure. "
09/01/1992 - "Renal insufficiency secondary to 2,8-dihydroxyadenine urolithiasis."
07/01/1982 - "Renal failure due to 2,8-dihydroxyadenine urolithiasis."
04/01/2010 - "Adenine phosphoribosyltransferase (APRT) deficiency is a rare autosomal recessive disorder causing 2,8-dihydroxyadenine stones and renal failure secondary to intratubular crystalline precipitation. "
01/01/2014 - "Adenine phosphoribosyltransferase deficiency (APRTD) is an under estimated genetic form of kidney stones and/or kidney failure, characterized by intratubular precipitation of 2,8-dihydroxyadenine crystals (2,8-DHA). "